A. Atzeni

Monthly Administration of a Continuous Erythropoietin Receptor Activator Provides Efficient Haemoglobin Control in Non-Dialysis Patients during Routine Clinical Practice

S. Heidenreich, Frank Leistikow, S. Zinn, 2012, Clinical Drug Investigation.

Mycobacterium tuberculosis and whole genome sequencing: a practical guide and online tools available for the clinical microbiologist.

Timothy D McHugh, G. Satta, A. Atzeni, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Acute renal failure in IgA nephropathy: aggravation by gross hematuria due to anticoagulant treatment.

S. Heidenreich, D. Lang, A. Atzeni, 2002, Journal of nephrology.

Mediators in Sepsis and Septic Shock

T. Büchner, J. Kienast, M. Kiehl, 1997 .

Geo-Environmental Risk Map of the coasts of Sardinia (+ 1:300.000 scale map)

G. Piras, A. Atzeni, F. Gregorio, 2000 .

Map of the geoenvironmental hazard on the coast of Sardinia - Italy

G. Piras, A. Atzeni, F. Gregorio, 2002 .

Erythropoiesis-stimulating agents: switch from intravenous to subcutaneous administration in hemodialyzed patients.

P. Bolasco, A. Atzeni, 2011, International journal of clinical pharmacology and therapeutics.